ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA corrects previous word on embattled valsartan maker's ban
fiercepharma
October 12, 2018After Zhejiang Huahai Pharmaceutical’s tainted valsartan API triggered a global recall, the FDA slapped an import ban on the drugmaker. But the agency made a confusing mistake in announcing the move—a mistake it just corrected.
Pharma Sources Insight July 2025
